Unlocking the recovery of dynamic range of focus with microporation therapeutics
Laser Scleral Microporation (LSM) is a therapy which represents the first biomechanical solution to the biomechanical problems of progressive presbyopia. The therapy is performed using the VisioLite® Ophthalmic Laser system developed by Ace Vision Group (AVG).
Today, having no biomechanical option able to meet the loss of dynamic range of focus (DRoF) that occurs with progressive presbyopia, the need remains unmet. Current solutions involve the exchange of refractive power either at the cornea or the lens with the newest solution being a variety of pharmacological miotic eye drops that artificially stimulate the iris muscle to create a “pinhole effect” to see more clearly at near.
Explore More Articles
Laser scleral microporation aids near vision without compromising distance vision
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Robert Ang, MD, discusses results of laser scleral microporation in patients with presbyopia.
read moreNew-generation software further improves precision of laser scleral microporation
VIENNA — In this Healio Video Perspective from the ESCRS meeting, Luca Gualdi, MD, speaks about the latest advances in laser scleral microporation. Laser scleral microporation (LSM, Ace Vision Group) is a treatment that restores accommodation in presbyopic patients by uncross-linking the scleral tissue that becomes stiff with age. It does so by performing arrays of micropores in …
read moreImprovement in Accommodation and Dynamic Range of Focus After Laser Scleral Microporation: A Potential Treatment for Presbyopia
Purpose: To examine the ocular changes in accommodation, wavefront aberrations, and dynamic range of focus (DROF) after laser scleral microporation (LSM) for treating presbyopia.
read more